by | Feb 12, 2026 | Lupus Foundation of America
This Black History Month, we’re centering the voices, stories, and experiences of Black lupus warriors. Throughout February, we’re sharing resources and community spaces designed to support and empower Black individuals navigating life with lupus.This post was...
by | Feb 12, 2026 | Lupus Foundation of America
This Black History Month, we’re centering the voices, stories, and experiences of Black lupus warriors. Throughout February, we’re sharing resources and community spaces designed to support and empower Black individuals navigating life with lupus.This post was...
by Alex Acevedo | Feb 3, 2026 | Lupus Foundation of America, News & Events, Research News
This afternoon, Congress took the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million – the most in history – for lupus programs at the Centers for Disease Control and Prevention (CDC),...
by Lupus Foundation, Ohio | Feb 3, 2026 | Lupus Foundation of America, News & Events
A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM) and systemic lupus erythematosus...
by Lupus Foundation, Ohio | Feb 3, 2026 | Lupus Foundation of America, News & Events
The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from AstraZeneca regarding the Biologics License Application (BLA) for subcutaneous (SC), self-administration of Saphnelo (anifrolumab).This post was...
by | Feb 1, 2026 | Lupus Foundation of America
For people living with lupus—especially Black women, who face higher rates of the disease and more severe symptoms—-Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re...
